Our News on Newswise

Newswise: 668c3974664c6_ViHCoverNo-ToC2019-03.jpg

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate...
9-Jul-2024 4:05 AM EDT Add to Favorites

Newswise: 666c8d4306ab3_ViHCoverNo-ToC2019-03.jpg

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.
18-Jun-2024 4:05 AM EDT Add to Favorites

Newswise: 666c6fad404a6_ViHCoverNo-ToC2019-03.jpg

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health...
17-Jun-2024 4:05 AM EDT Add to Favorites

Newswise: 663127dac6f0d_BoD2024-2025SF-NW.jpg

ISPOR Announces 2024-2025 Board of Directors

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the results of its recent elections. The Society’s membership selected its new president-elect and 4 new board members.
28-May-2024 4:05 AM EDT Add to Favorites

Newswise: 663e3399618e6_ViHCoverNo-ToC2019-03.jpg

When and How to Conduct Health Technology Assessments for Biosimilars?

ISPOR announced the publication of a report from the ISPOR Biosimilars Special Interest Group highlighting the need for clearer guidance on when and how to conduct health technology assessments (HTAs) for biosimilars.
13-May-2024 4:05 AM EDT Add to Favorites

Newswise: 6626adff4d129_Patient-Summit-2024150x200NW-SF.jpg

ISPOR Announces Patient-Centered Research Summit 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the sessions and speakers for its Patient-Centered Research Summit 2024. The Summit is scheduled to be held May 5 in Atlanta, GA, USA and is co-located with the...
22-Apr-2024 9:05 AM EDT Add to Favorites

Newswise: 66215b612f325_ISPOR-2024150x200NW-SF.jpg

ISPOR 2024 Plenaries and Speakers Announced

ISPOR announced the plenary sessions and speakers for ISPOR 2024, its annual international conference., and the leading global conference for health economics and outcomes research (HEOR). ISPOR 2024 will be held May 5-8 in Atlanta, GA, USA.
22-Apr-2024 4:05 AM EDT Add to Favorites

Newswise: 66103a448daf4_ViHCoverNo-ToC2019-03.jpg

ISPOR Global Panel Proposes New Structure to Improve Definitions of Digital Health Interventions

ISPOR—The Professional Society for Health Economics and Outcomes Research announced the publication of a report from the ISPOR Digital Health Special Interest Group that proposes a new framework to help standardize and clarify definitions used for...
9-Apr-2024 4:05 AM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

About

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.

ISPOR’s community of 14,000 individual and chapter members from more than 100 countries includes a wide variety of healthcare stakeholders, including researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations. The Society’s leadership has served as an unbiased resource and catalyst for innovation in the field for more than 25 years.

Twitter

close
0.2664